[Hybridization in situ: methodology and applications to the analysis of phenomena of gene expression in endocrine glands and the nervous system].
Techniques of in situ hybridization for the detection of mRNA on histological sections are described and commented upon. The main applications of the procedure are discussed and the potential uses of this new method for the analysis of gene expression in endocrine and nervous systems are presented.
D000313:Adrenal Medulla / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D015740:Calcitonin Gene-Related Peptide; D002417:Cattle; D003346:Corticotropin-Releasing Hormone / Q000235:genetics; D004247:DNA; D004702:Endocrine Glands / Q000378:metabolism*; D005786:Gene Expression Regulation; D013006:Growth Hormone / Q000235:genetics; D006801:Humans; D009419:Nerve Tissue Proteins / Q000235:genetics; D009420:Nervous System / Q000378:metabolism*; D009693:Nucleic Acid Hybridization; D010179:Pancreas / Q000378:metabolism; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism; D010903:Pituitary Gland, Anterior / Q000378:metabolism; D010920:Placenta / Q000378:metabolism; D011333:Pro-Opiomelanocortin / Q000235:genetics; D011388:Prolactin / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011910:Rats, Brattleboro; D013973:Thyrotropin-Releasing Hormone / Q000235:genetics; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics; D014667:Vasopressins / Q000235:genetics
D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D014667:Vasopressins; D013973:Thyrotropin-Releasing Hormone; D011333:Pro-Opiomelanocortin; D011388:Prolactin; D013006:Growth Hormone; D004247:DNA; D003346:Corticotropin-Releasing Hormone; D014446:Tyrosine 3-Monooxygenase; D015740:Calcitonin Gene-Related Peptide
L'hybridation in situ: méthodologie et applications à l'analyse des phénomènes d'expression génique dans les glandes endocrines et le système nerveux.